CoreAge Rx vs Prime Health
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Prime Health head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 60 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Prime Health a bad call — it's best for people seeking a clinician-reviewed program who confirm the actual recurring charge, location eligibility and guarantee conditions before enrolling. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Prime Health |
|---|---|---|
| Brief Score | 94/100 (A) | 60/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Current program charge unconfirmed Compounded medication with consultation and four-week supply; billed every 28 days, extra requested clinical/lab services may cost more. Louisiana eligibility conflicts across sources. Cancel by email to stop future charges; paid fees ordinarily nonrefundable. Conditional sixteen-week/10% guarantee has prior-medication exclusions and evidence deadlines; incidental costs excluded. Full price detailsCompounded semaglutide offered under the program terms; complete selected-prescription quote unknown; program includes clinician consultation and four weeks of medication, recurring billing every 28 days, extra services may cost more |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Current program charge unconfirmed Compounded medication with consultation and four-week supply; billed every 28 days, extra requested clinical/lab services may cost more. Louisiana eligibility conflicts across sources. Cancel by email to stop future charges; paid fees ordinarily nonrefundable. Conditional sixteen-week/10% guarantee has prior-medication exclusions and evidence deadlines; incidental costs excluded. Full price detailsCompounded tirzepatide offered under the program terms; complete selected-prescription quote unknown; program includes clinician consultation and four weeks of medication, recurring billing every 28 days, extra services may cost more |
| Coverage | US only; restrictions by state, confirmed at intake | Homepage excludes Louisiana while terms say all 50 states plus Washington DC; actual patient-state prescribing access requires confirmation |
| Brand-name access | Not confirmed | The reviewed current program describes compounded medications; a named branded GLP-1 offer was not established. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Prime Health: Four-week supply billed every 28 days; complete quote unconfirmed. Louisiana access conflicts across pages. Ordinary paid fees nonrefundable; sixteen-week guarantee requires eligibility, adherence and timed verification.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.